Framingham Issue 1 2023
MAT-DK-2200537 (ver.1.0) 02 2023
How to get your head around optimal sequencing in RRMM?
Juggling the impact of disease, treatment, study participation on patients’ lives
NK Cells, RRMM
Review: NK cell therapy in relapsed refractory multiple myeloma
Framingham Issue 2 2023
MRD, NDMM, RRMM